121 related articles for article (PubMed ID: 33495917)
41. Challenges in the delivery of quality breast cancer care: initiation of adjuvant hormone therapy at an urban safety net hospital.
Crowley MM; McCoy ME; Bak SM; Caron SE; Ko NY; Kachnic LA; Alvis F; Battaglia TA
J Oncol Pract; 2014 Mar; 10(2):e107-12. PubMed ID: 24345397
[TBL] [Abstract][Full Text] [Related]
42. Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement.
Christopherson K; Lei X; Barcenas C; Buchholz TA; Garg N; Hoffman KE; Kuerer HM; Mittendorf E; Perkins G; Shaitelman SF; Smith GL; Stauder M; Strom EA; Tereffe W; Woodward WA; Smith BD
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):574-581. PubMed ID: 30851348
[TBL] [Abstract][Full Text] [Related]
43. The quality of surgical care in safety net hospitals: a systematic review.
Mouch CA; Regenbogen SE; Revels SL; Wong SL; Lemak CH; Morris AM
Surgery; 2014 May; 155(5):826-38. PubMed ID: 24787109
[TBL] [Abstract][Full Text] [Related]
44. Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer.
Gagliato Dde M; Gonzalez-Angulo AM; Lei X; Theriault RL; Giordano SH; Valero V; Hortobagyi GN; Chavez-Macgregor M
J Clin Oncol; 2014 Mar; 32(8):735-44. PubMed ID: 24470007
[TBL] [Abstract][Full Text] [Related]
45. Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation.
Keilty D; Nezafat Namini S; Swain M; Maganti M; Cil TD; McCready DR; Cescon DW; Amir E; Fleming R; Mulligan AM; Fyles A; Croke JM; Liu FF; Levin W; Koch CA; Han K
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):676-685. PubMed ID: 32407932
[TBL] [Abstract][Full Text] [Related]
46. Esophageal Cancer Presentation, Treatment, and Outcomes Vary With Hospital Safety-Net Burden.
Sridhar P; Bhatt M; Qureshi MM; Asokan S; Truong MT; Suzuki K; Mak KS; Litle VR
Ann Thorac Surg; 2019 May; 107(5):1472-1479. PubMed ID: 30605641
[TBL] [Abstract][Full Text] [Related]
47. Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital--a closer look into cause-specific mortality.
Balabram D; Turra CM; Gobbi H
BMC Cancer; 2013 Sep; 13():434. PubMed ID: 24063763
[TBL] [Abstract][Full Text] [Related]
48. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
Resende U; Cabello C; Ramalho SOB; Zeferino LC
BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
[TBL] [Abstract][Full Text] [Related]
49. High Initiation of Adjuvant Hormonal Therapy Among Uninsured Stages I-III Breast Cancer Patients Treated in a Safety-Net Healthcare System.
Murphy CC; Tiro JA; Jean GW; Balasubramian BA; Alvarez CA
J Womens Health (Larchmt); 2017 Jun; 26(6):655-661. PubMed ID: 28296574
[TBL] [Abstract][Full Text] [Related]
50. Increased 30-day readmission rate after craniotomy for tumor resection at safety net hospitals in small metropolitan areas.
Nathan NH; Connor M; Sizdahkhani S; Ding L; Mack WJ; Attenello FJ
J Neurooncol; 2020 May; 148(1):141-154. PubMed ID: 32346836
[TBL] [Abstract][Full Text] [Related]
51. Factors influencing survival among patients with HER2-positive metastatic breast cancer treated with trastuzumab.
Blanchette PS; Desautels DN; Pond GR; Bartlett JMS; Nofech-Mozes S; Yaffe MJ; Pritchard KI
Breast Cancer Res Treat; 2018 Jul; 170(1):169-177. PubMed ID: 29520532
[TBL] [Abstract][Full Text] [Related]
52. Health care disparities among octogenarians and nonagenarians with stage III lung cancer.
Cassidy RJ; Zhang X; Switchenko JM; Patel PR; Shelton JW; Tian S; Nanda RH; Steuer CE; Pillai RN; Owonikoko TK; Ramalingam SS; Fernandez FG; Force SD; Gillespie TW; Curran WJ; Higgins KA
Cancer; 2018 Feb; 124(4):775-784. PubMed ID: 29315497
[TBL] [Abstract][Full Text] [Related]
53. TGF-β1 precursor and CD8 are potential prognostic and predictive markers in operated breast cancer.
Yu HM; Yang JL; Jiao SC; Wang JD; Li Y
J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):51-58. PubMed ID: 24496679
[TBL] [Abstract][Full Text] [Related]
54. Impact of Treatment Coordination on Overall Survival in Rectal Cancer.
Biju K; Zhang GQ; Stem M; Sahyoun R; Safar B; Atallah C; Efron JE; Rajput A
Clin Colorectal Cancer; 2021 Sep; 20(3):187-196. PubMed ID: 33618972
[TBL] [Abstract][Full Text] [Related]
55. Financial Stability of Level I Trauma Centers Within Safety-Net Hospitals.
Knowlton LM; Morris AM; Tennakoon L; Spain DA; Staudenmayer KL
J Am Coll Surg; 2018 Aug; 227(2):172-180. PubMed ID: 29680414
[TBL] [Abstract][Full Text] [Related]
56. Clinical and financial outcomes of pulmonary resection for lung cancer in safety-net hospitals.
Sakowitz S; Verma A; Mabeza RM; Cho NY; Hadaya J; Toste P; Benharash P
J Thorac Cardiovasc Surg; 2023 Apr; 165(4):1577-1584.e1. PubMed ID: 36328819
[TBL] [Abstract][Full Text] [Related]
57. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.
Nagar H; Yan W; Christos P; Chao KSC; Nori D; Ravi A
Am J Clin Oncol; 2017 Jun; 40(3):300-305. PubMed ID: 25333731
[TBL] [Abstract][Full Text] [Related]
58. Safety-net hospitals versus non-safety centers and clinical outcomes after trans-catheter aortic valve replacement.
Sheikh MA; Deo SV; Riaz H; Raza S; Altarabsheh SE; Wilson B; Elgudin Y; Cmolik B; Pelletier M; Markowitz AH
Catheter Cardiovasc Interv; 2021 Feb; 97(3):E425-E430. PubMed ID: 32681697
[TBL] [Abstract][Full Text] [Related]
59. Inflammatory Breast Cancer at the Extremes of Age.
Adesoye T; Babayemi O; Postlewait LM; DeSnyder SM; Sun SX; Woodward WA; Ueno NT; Hunt KK; Lucci A; Teshome M
Ann Surg Oncol; 2021 Oct; 28(10):5626-5634. PubMed ID: 34292426
[TBL] [Abstract][Full Text] [Related]
60. Identifying the barriers to gastric cancer care at safety-net hospitals: A novel comparison of a safety-net hospital to a neighboring quaternary referral academic center in the same healthcare system.
Zaidi MY; Rappaport JM; Ethun CG; Gillespie T; Hawk N; Chawla S; Cardona K; Maithel SK; Russell MC
J Surg Oncol; 2019 Jan; 119(1):64-70. PubMed ID: 30481370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
